Baker G. Daniel's most recent trade in Artiva Biotherapeutics Inc was a trade of 16,250 Director Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Sept. 10, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Artiva Biotherapeutics Inc | Daniel G. Baker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2026 | 16,250 | 16,250 | - | - | Director Stock Option (Right to Buy) | |
| Artiva Biotherapeutics Inc | Daniel G. Baker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Sep 2026 | 13,750 | 13,750 | - | - | Director Stock Option (Right to Buy) | |
| Shattuck Labs Inc | Daniel G. Baker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2026 | 81,000 | 81,000 | - | - | Stock Option (Right to Buy) | |
| Cue Biopharma Inc | Daniel G. Baker | CHIEF DEVELOPMENT OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Cue Biopharma Inc | Daniel G. Baker | CHIEF DEVELOPMENT OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2025 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Shattuck Labs Inc | Daniel G. Baker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Aug 2025 | 66,300 | 66,300 | - | - | Stock Option (Right to Buy) | |
| Artiva Biotherapeutics Inc | Daniel G. Baker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2025 | 13,750 | 13,750 | - | - | Director Stock Option (Right to Buy) | |
| Cue Biopharma Inc | Daniel G. Baker | CHIEF DEVELOPMENT OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2025 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Artiva Biotherapeutics Inc | Daniel G. Baker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 27,500 | 27,500 | - | - | Director Stock Option (Right to Buy) | |
| Cue Biopharma Inc | Baker G. Daniel | CHIEF DEVELOPMENT OFFICER | 25 Nov 2024 | 200,000 | 200,000 | - | - | Stock Option (right to buy) |